New insider activity at Opko Health ( (OPK) ) has taken place on April 9, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CEO & Chairman Phillip Frost has made a significant investment in Opko Health by purchasing 125,000 shares of the company’s stock. This transaction is valued at $183,750, showcasing his confidence in the company’s future prospects.
Spark’s Take on OPK Stock
According to Spark, TipRanks’ AI Analyst, OPK is a Neutral.
Opko Health’s overall score reflects its financial struggles, with declining revenues and cash flow issues as significant concerns. However, the positive technical indicators and strategic asset sale to Labcorp provide some optimism. Mixed earnings call sentiment and a challenging valuation context moderate the outlook.
To see Spark’s full report on OPK stock, click here.
More about Opko Health
YTD Price Performance: 5.52%
Average Trading Volume: 4,967,643
Technical Sentiment Signal: Buy
Current Market Cap: $1.04B
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue